Figure 1From: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells Release profiles of tyrphostin AG-1478 from NLC-C and NLC-D samples in PBS pH 7.4/ethanol mixture (80:20 v/v) at 37 ± 0.1°C, expressed as percentage wt% of released drug as a function of incubation time. Each value is the mean of three experiments.Back to article page